-+ 0.00%
-+ 0.00%
-+ 0.00%

PURETECH ANNOUNCES PRESENTATION OF PHASE 1B RESULTS FOR LYT-200 IN RELAPSED/REFRACTORY (R/R) HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) AND ACUTE MYELOID LEUKEMIA (AML) AT ESMO 2026

Reuters·10/19/2026 06:00:00

Please log in to view news